Company intelligence / Profile preview

Brinter

Winston Salem, North Carolina, United Statesbrinter.com ↗
Ownership
Private
Employees
~17
Development stage
Preclinical
01

Overview

Brinter develops proprietary modular platforms for the scalable manufacturing of resorbable, biomimetic, patient-specific tissue implants ("BioMods™") using advanced multi-material/multi-modal additive manufacturing. Their main therapeutic focus to date has been on orthopedic cartilage repair. The company also sells its own line of research and commercial-grade bioprinters. No clinical trial results have been reported; products are currently at the pre-clinical stage or used as research tools.

Therapeutic areas
OtherDermatology
Modalities
Device (3D bioprinted implants)Biologic (biocomposite/bio-synthetic mesh implants)Cell therapy (potential future applications in organ bioprinting)
Industry
Implantable Medical Devices
02

Partnerships

Collaborations with clinics/hospitals/research institutions/CMOs/CROs; strategic interest from major MedTech/pharma companies such as GE HealthCare, J&J MedTech, Roche mentioned as potential partners/investors but not confirmed formal partnerships yet.

Beyond the preview

Go deeper on Brinter.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brinter.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call